Human ATP-binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred

Citation
At. Remaley et al., Human ATP-binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred, P NAS US, 96(22), 1999, pp. 12685-12690
Citations number
49
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN journal
00278424 → ACNP
Volume
96
Issue
22
Year of publication
1999
Pages
12685 - 12690
Database
ISI
SICI code
0027-8424(19991026)96:22<12685:HACT1(>2.0.ZU;2-U
Abstract
Tangier disease is characterized by low serum high density lipoproteins and a biochemical defect in the cellular efflux of lipids to high density lipo proteins. ABC1. a member of the ATP-binding cassette family. recently has b een identified as the defective gene in Tangier disease. We report here the organization of the human ABC1 gene and the identification of a mutation i n the ABC1 gene from the original Tangier disease kindred. The organization of the human ABC1 gene is similar to that of the mouse ABC1 gene and other related ABC genes. The ABC1 gene contains 49 exons that range in size from 33 to 249 bp and is over 70 kb in length. Sequence analysis of the ABC1 ge ne revealed that the proband for Tangier disease was homozygous for a delet ion of nucleotides 3283 and 3284 (TC) in exon 22. The deletion results in a frameshift mutation and a premature stop codon starting at nucleotide 3375 . The product is predicted to encode a nonfunctional protein of 1.084 aa, w hich is approximately half the size of the full-length ABC1 protein. The lo ss of a Mn/1 restriction site, which results from the deletion, was used to establish the genotype of the rest of the kindred. In summary, we report o n the genomic organization of the human ABC1 gene and identify a frameshift mutation in the ABC1 gene of the index Ease of Tangier disease. These resu lts will be useful in the future characterization of the structure and func tion of the ABC1 gene and the analysis of additional ABC1 mutations in pati ents with Tangier disease.